Critical updates in breast cancer care: Don’t miss the Breast Cancer Symposium on Feb. 23

Register today to join breast cancer colleagues at Karmanos Cancer Institute and Wayne State University’s annual Breast Cancer Symposium

This year’s Breast Cancer Symposium, hosted by the Barbara Ann Karmanos Cancer Institute and Wayne State University, will feature key updates in breast cancer care, from screening to diagnosis, management of medical and surgical treatment, side effect management, and palliative care.

The annual Breast Cancer Symposium provides a platform for experts to share insights on critical aspects of breast cancer research and treatment. Co-program directors Hadeel Assad, M.D., medical oncologist, and Lydia Choi, M.D., breast surgeon, both members of the Breast Cancer Multidisciplinary Team at Karmanos, welcome two keynote speakers. N. Lynn Henry, M.D., Ph.D., the Daniel F. Hayes, M.D., Breast Cancer Research Professor and interim division chief of the Division of Hematology/Oncology at the University of Michigan’s (U-M) Rogel Cancer Center, will concentrate on the updates and management of HR-positive breast cancer, while Melissa Pilewski, M.D., FACS, associate professor of Surgery and director of the Breast Care Center at U-M’s Rogel Cancer Center, will zero in on the updates in surgical management of breast cancer.

Download the Flyer

Where

The Somerset Inn

2601 w. Big Beaver Road

Troy, MI 48084

Registration

Pre-registration is encouraged. The deadline to register is Thursday, Feb. 22, 2024.

Register Is Now Closed 

Attending this year’s symposium is $125 for physicians and pharmacists; $50 for mid-level providers, retired physicians, and other allied health providers; $25 for nurses and CTO staff; and $20 for fellows, residents and medical students, which is refundable upon attendance.

This conference is geared toward general physicians, surgeons, fellows, residents, students, pathologists, radiation oncologists, pharmacists, physician assistants, nurse practitioners, and nurses in the field fo hematology and oncology.

Educational Objectives

Upon completion of this program, the participant will:

1. Integrate diagnostic and therapeutic strategies used in the multimodality treatment of patients with breast cancer.
2. Specify the use of new agents, both cytotoxic and biologic, and their uses in treating breast cancer.
3. Identify the latest research findings in all areas of breast cancers and how the updated research could impact future decision-making in the diagnosis and treatment of these cancers.

Accreditation

This activity has been approved for up to 5.75 AMA PRA Category 1 Credits™ provided by Wayne State University School of Medicine and Karmanos Cancer Institute.

Please contact Pamela Sydorchuk, symposium coordinator, at symposium@karmanos.org or call 313-576-8746.

For more professional education opportunities at Karmanos, click here.